The new study is “an important part of the bigger picture of where we are headed as a nation” with psychedelics, says Dr. Joshua Siegel of Washington University in St. Louis. “It’s important to understand what’s happening in terms of the health care side of things. It’s important to understand what’s happening recreationally and legally.”…
Wall Street’s sudden exuberance for hallucinogens has rankled longtime advocates and philanthropists, who dreamed of making low-cost psychedelics widely available for mental health and personal growth. Instead, many now see a very different future for drugs like psilocybin and LSD: as expensive, specialty medications controlled by a handful of biotech companies… “We’re a victim of…
A Colorado biosciences company is hoping that one day patients with anxiety will be able to get a prescription from their doctor to microdose psychedelic mushrooms, pick it up at the local pharmacy and have it covered by insurance. Joel Stanley is the CEO of Ajna BioSciences in Littleton, Colorado. He says the company received…
This year [2023], Oregon became the first state to introduce psilocybin… and… been learning as they go. Since the first facility in Oregon opened to the public this May, 600… [to upwards of 700 adults] have participated in the program. Original Article (Oregon Public Broadcasting & Oregon Live & Seattle Times):Oregon psilocybin advocates reflect on…
…from a financial perspective, the inconsistency of psychedelic experiences and the fact that they require hands-on psychological therapy make for a difficult investment pitch. Treatment is typically administered in a specialized facility under supervision by psychiatric professionals, which is costlier and harder to scale up than simply providing medicine. The industry’s market performance reflects such…
MAPS PBC [Public Benefit Corporation) has rebranded to Lykos Therapeutics [a for-profit public benefit corporation (“PBC”)], (“Lykos”), the greek word for wolf. MAPS PBC spun out of its parent organization MAPS (Multidisciplinary Association for Psychedelic Studies)… clinical development effort of MDMA-assisted therapy [midomafetamine capsules used in combination with psychological intervention], which includes talk therapy, and…
In a letter sent to Congressional Cannabis Caucus co-chair Rep. Earl Blumenauer (D-OR), DEA Acting Chief of the Office of Congressional Affairs Michael Miller gave a general overview… “DEA has the final authority to schedule, reschedule, or deschedule a drug under the Controlled Substances Act, after considering the relevant statutory and regulatory criteria and HHS’s…
…a new criminal complaint suggests the outlines of the case that federal authorities are building. That criminal complaint, filed Dec. 12, 2023, in U.S. District Court in Portland, reveals that law enforcement are investigating a trend of drug trafficking organizations using “Honduran nationals to distribute bulk amounts of fentanyl…in the western United States.” It names…
Federal researchers now say drug overdoses are a leading cause of death among young Americans age 18-45. In 2023 the overdose death rate topped 112,000 in a 12 month period for the first time, according to the Centers for Disease Control and Prevention… total annual spending on the drug war now tops $40 billion a…
…a three-judge panel of the U.S. Court of Appeals for the Ninth Circuit rejected the doctor’s request for a rehearing of an earlier court decision that returned the matter to the Drug Enforcement Administration (DEA). …in a one-line ruling handed down… the court denied the rehearing request without explaining its reasoning. Given that Aggarwal’s rescheduling…
Recent Comments